Logo

American Heart Association

  2
  0


Final ID: MDP1523

Prevalence, Clinical Correlates, and Outcomes of Tricuspid Regurgitation Among Older Adults: The Atherosclerosis Risk in Communities Study

Abstract Body (Do not enter title and authors here): Introduction: Tricuspid regurgitation (TR) prevalence increases with age and is associated with higher mortality. Limited data exist regarding the prognostic relevance of TR among older adults in the general population.

Objective: To estimate the prevalence of TR in late life, identify cardiac structural and functional measures associated with TR severity, and determine the prognostic relevance of TR severity.

Methods: In the community-based Atherosclerosis Risk in Communities (ARIC) study, 3,046 participants underwent protocol echocardiography at the 7th study visit (2018-2019). TR severity was assessed qualitatively as none/trace, mild, moderate, or severe by a board-certified cardiologist. Dyspnea was assessed using the modified Medical Research Council questionnaire and post-Visit 7 mortality was ascertained through the National Death Index. Cross-sectional associations of TR severity with clinical characteristics, echocardiographic measures, and dyspnea were assessed using multivariable linear and logistic regression models. Associations with death were assessed using Cox proportional hazard models adjusted for demographics.

Results: Mean age was 81±4 years, 58% were women, 25% reported Black race, and mean LVEF was 63±8%. TR prevalence was 30% mild, 9% moderate, and 1% severe. Greater TR severity was associated with older age, female sex, higher HF prevalence, and loop diuretic use. Greater TR severity was also associated with lower LVEF, worse LV diastolic function (higher LAVi, E/A, E/e’ septal), higher NT-proBNP, higher prevalence of moderate-severe mitral regurgitation, greater pulmonary artery systolic pressure, and larger RV size. Severe TR was associated with higher odds of moderate-severe dyspnea (OR:2.3 [1.2-4.5], p=0.012). During follow-up (median 2.1 years [IQR 1.7-2.5]), 192 participants died. Higher TR severity was associated with greater mortality (Figure). Compared to participants with none/trace TR, even mild TR was associated with a 64% greater mortality risk.

Conclusion: TR is common in late life and is associated with greater left heart disease despite generally preserved LVEF. Greater TR severity, even when mild, is a marker of increased mortality. Longer follow-up is needed to determine whether this risk is independent of concomitant left heart dysfunction.
  • Kharidia, Khush  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Shah, Amil  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Giugni, Fernando  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Lamberson, Victoria  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Yang, Yimin  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Claggett, Brian  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Van't Hof, Jeremy  ( University of Minnesota , Minneapolis , Minnesota , United States )
  • Wagenknecht, Lynne  ( Wake Forest University , Winston-Salem , North Carolina , United States )
  • Mosley, Thomas  ( UNIV MS MEDICAL CTR , Jackson , Mississippi , United States )
  • Skali, Hicham  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Khush Kharidia: DO NOT have relevant financial relationships | Amil Shah: DO have relevant financial relationships ; Advisor:Philips Ultrasound:Past (completed) ; Advisor:Janssen:Past (completed) | Fernando Giugni: DO NOT have relevant financial relationships | Victoria Lamberson: DO NOT have relevant financial relationships | Yimin Yang: DO NOT have relevant financial relationships | Brian Claggett: DO have relevant financial relationships ; Consultant:Cardior:Active (exists now) ; Consultant:Eli Lilly:Active (exists now) ; Consultant:CVRx:Past (completed) ; Consultant:Intellia:Active (exists now) ; Consultant:Cytokinetics:Past (completed) ; Consultant:Cardurion:Active (exists now) | Jeremy Van't Hof: DO NOT have relevant financial relationships | Lynne Wagenknecht: No Answer | Thomas Mosley: DO NOT have relevant financial relationships | Hicham Skali: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:
More abstracts on this topic:
A Real-World Pilot for Diagnostic Yield of Cardiac CTA vs Echocardiography in Acute Ischemic Stroke

Chakravarthula Nitin Ramanujam, Milani Marcus, Tessmer Megan, Staugaitis Abbey, Akimoto Kai, Markowitz Jeremy, Kalra Rajat, Nijjar Prabhjot, Streib Christopher

Accumulation of Epicardial Adipose Tissue as a Marker of Diastolic Dysfunction in Patients With Preserved Left Ventricular Ejection Fraction Undergoing Coronary Computed Tomography Angiograph

Ishikawa Hirotoshi, Kasayuki Noriaki, Fukuda Daiju, Otsuka Kenichiro, Sugiyama Takatoshi, Yamaura Hiroki, Hojo Kana, Kawa Yoshinori, Shintani Ako, Ito Asahiro, Yamazaki Takanori

More abstracts from these authors:
Large-Scale Proteomics Identifies Novel Circulating Markers of Pulmonary Hypertension: the Atherosclerosis Risk in Communities Study

Giugni Fernando, Santos Mario, Yang Yimin, Lamberson Victoria, Claggett Brian, Hoogeveen Ron, Ballantyne Christie, Yu Bing, Shah Amil

Changes in Left Ventricular Systolic Function in Late Life: The Atherosclerosis Risk in Communities (ARIC) Study

Jensen Anne Marie, Biering-srensen Tor, Shah Amil, Yang Yimin, Lamberson Victoria, Claggett Brian, Skali Hicham, Matsushita Kuni, Lutsey Pamela, Butler Kenneth, Kitzman Dalane

You have to be authorized to contact abstract author. Please, Login
Not Available